EUVIMEDEUVIMED entdecken
Open Access

The inter‐laboratory validation study of EpiSensA for predicting skin sensitization potential

Hideyuki Mizumachi iD, Mika Watanabe, Mayu Ikezumi, Michika Kajiwara, Michiyo Yasuda, Makoto Mizuno iD, Noriyasu Imai iD, Megumi Sakuma, Momoko Shibata, Shin-Ichi Watanabe, Junko Motoyama, David Basketter und 9 weitere

Journal of Applied Toxicology · 2024

DOI: 10.1002/jat.4559 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Applied Toxicology, 2024. Verfasst von Hideyuki Mizumachi und 20 weiteren Autor:innen. Beteiligte Einrichtung: R&D Safety Science Research, Kao Corporation, 2606 Akabane, Ichikai-Machi, Haga-Gun, Tochigi, 321-3497, Japan. Hauptthemen laut MEDLINE: Allergens, Dermatitis, Allergic Contact. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural EPA, Long-range Research Initiative by the Japan Chemical Industry Association, Japan Agency for Medical Research and Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The Epidermal Sensitization Assay (EpiSensA) is a reconstructed human epidermis (RhE)‐based gene expression assay for predicting the skin sensitization potential of chemicals. Since the RhE model is covered by a stratified stratum corneum, various kinds of test chemicals, including lipophilic ones and pre‐/pro‐haptens, can be tested with a route of exposure akin to an in vivo assay and human exposure. This article presents the results of a formally managed validation study of the EpiSensA that was carried out by three participating laboratories. The purpose of this validation study was to assess transferability of the EpiSensA to new laboratories along with its within‐ (WLR) and between‐laboratory reproducibility (BLR). The validation study was organized into two independent stages. As demonstrated during the first stage, where three sensitizers and one non‐sensitizer were correctly predicted by all participating laboratories, the EpiSensA was successfully transferred to all three participating laboratories. For Phase I of the second stage, each participating laboratory performed three experiments with an identical set of 15 coded test chemicals resulting in WLR of 93.3%, 93.3%, and 86.7%, respectively. Furthermore, when the results from the 15 test chemicals were combined with those of the additional 12 chemicals tested in Phase II of the second stage, the BLR for 27 test chemicals was 88.9%. Moreover, the predictive capacity among the three laboratories showed 92.6% sensitivity, 63.0% specificity, 82.7% accuracy, and 77.8% balanced accuracy based on murine local lymph node assay (LLNA) results. Overall, this validation study concluded that EpiSensA is easily transferable and sufficiently robust for assessing the skin sensitization potential of chemicals.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AllergensDermatitis, Allergic ContactHumansAnimalsMiceReproducibility of ResultsEpidermisSkinHaptensLocal Lymph Node AssayAnimal Testing Alternatives

Stichwörter der Autor:innen

gene expressionlipophilic chemicalnon-animal test methodreconstructed human epidermisskin sensitizationvalidation study

Substanzen

AllergensHaptens

Autor:innen und Institutionen

  • R&D Safety Science Research, Kao Corporation, 2606 Akabane, Ichikai-Machi, Haga-Gun, Tochigi, 321-3497, Japan.
  • Food and Drug Safety Center, Hatano Research Institute, 729-5 Ochiai, Hadano, Kanagawa, 257-8523, Japan.
  • Safety and Analytical Research Laboratories, KOSÉ Corporation, 48-18 Sakae-cho, Kita-ku, Tokyo, 114-0005, Japan.
  • Safety Research Science Laboratory, LION Corporation, 100 Tajima, Odawara-shi, Kanagawa, 256-0811, Japan.
  • DABMEB Consultancy Ltd., Kingswood, Gloucestershire, GL12 8RN, UK.
  • Services and Consultation on Alternative Methods (SeCAM), Magliaso, Switzerland and Swiss 3R Competence Centre (3RCC), Bern, Switzerland.

ORCID-Profile: Hideyuki Mizumachi, Makoto Mizuno, Noriyasu Imai, Masahiro Takeyoshi

Förderung

  • Intramural EPA
  • Long-range Research Initiative by the Japan Chemical Industry Association
  • Japan Agency for Medical Research and Development
  • Japanese Society for Alternative to Animal Experiments

Zitieren

APA

Mizumachi, H., Watanabe, M., Ikezumi, M., Kajiwara, M., Yasuda, M., Mizuno, M., Imai, N., Sakuma, M., Shibata, M., Watanabe, S. I., Motoyama, J., Basketter, D., Eskes, C., Hoffmann, S., Lehmann, D. M., Ashikaga, T., Sozu, T., Takeyoshi, M., Suzuki, S., …, & Kojima, H. (2024). The inter‐laboratory validation study of EpiSensA for predicting skin sensitization potential. Journal of Applied Toxicology. https://doi.org/10.1002/jat.4559

Vancouver

Mizumachi H, Watanabe M, Ikezumi M, Kajiwara M, Yasuda M, Mizuno M, et al. The inter‐laboratory validation study of EpiSensA for predicting skin sensitization potential. Journal of Applied Toxicology. 2024. doi:10.1002/jat.4559

BibTeX
@article{Mizumachi2024,
  author = {Mizumachi, Hideyuki and Watanabe, Mika and Ikezumi, Mayu and Kajiwara, Michika and Yasuda, Michiyo and Mizuno, Makoto and Imai, Noriyasu and Sakuma, Megumi and Shibata, Momoko and Watanabe, Shin-Ichi and Motoyama, Junko and Basketter, David and Eskes, Chantra and Hoffmann, Sebastian and Lehmann, David M and Ashikaga, Takao and Sozu, Takashi and Takeyoshi, Masahiro and Suzuki, Sho and Miyazawa, Masaaki and Kojima, Hajime},
  title = {The inter‐laboratory validation study of EpiSensA for predicting skin sensitization potential},
  journal = {Journal of Applied Toxicology},
  year = {2024},
  doi = {10.1002/jat.4559}
}
Kostenlos starten →